Mitogen-activated protein kinase-defective Candida albicans is avirulent in a novel model of localized murine candidiasis

被引:8
作者
Guhad, FA
Jensen, HE
Aalbaek, B
Csank, C
Mohamed, O
Harcus, D
Thomas, DY
Whiteway, M
Hau, J
机构
[1] Univ Uppsala, Ctr Biomed, Dept Physiol, Div Comparat Med, S-75123 Uppsala, Sweden
[2] Royal Vet & Agr Univ, Dept Pharmacol & Pathobiol, Copenhagen, Denmark
[3] Royal Vet & Agr Univ, Dept Microbiol, Copenhagen, Denmark
[4] Natl Res Council Canada, Biotechnol Res Inst, Eukaryot Genet Grp, Montreal, PQ H4P 2R2, Canada
[5] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[6] Hotel Dieu, Ctr Rech, Montreal, PQ, Canada
[7] McGill Univ, Dept Biol, Montreal, PQ, Canada
基金
英国医学研究理事会;
关键词
virulence; pathology; animal model; mastitis;
D O I
10.1016/S0378-1097(98)00323-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida albicans strains with a deletion of the mitogen-activated protein kinase CEK1 gene are defective in the yeast to hyphal transition on solid surfaces in vitro. The virulence of a cek1 Delta/cek1 Delta null mutant strain was compared with its wild-type parent strain (WT) in a novel model of localized candidiasis. The mammary glands of lactating mice (at day 5 postpartum) were infected for 2, 4 and 6 days with 50 mu l suspension containing 1 x 10(5), 1 x 10(6) and 1 x 10(7) blastospores before death. Infected and non-infected control glands were evaluated pathologically, All animals infected with cek1 Delta/cek1 Delta null mutant strains showed no lesions while 65% of animals infected with the WT strain had severe lesions characterized by widespread heterophilic infiltration, necrosis, and abscess formation. As an additional control, animals infected with the disrupted strain complemented with the WT CEK1, on a replicating plasmid, also showed severe pathological changes similar to the WT strain. These results clearly demonstrate that the CEK1 gene codes for a virulence determinant of C. albicans and that the mouse mastitis model is well suited for the discriminative study of the pathogenicity of different C. albicans strains. (C) 1998 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 17 条
[1]  
AOKI S, 1990, ZBL BAKT-INT J MED M, V273, P332
[2]   REDUCED VIRULENCE OF CANDIDA-ALBICANS MUTANTS AFFECTED IN MULTIDRUG-RESISTANCE [J].
BECKER, JM ;
HENRY, LK ;
JIANG, WD ;
KOLTIN, Y .
INFECTION AND IMMUNITY, 1995, 63 (11) :4515-4518
[3]   ATTENUATED VIRULENCE OF CHITIN-DEFICIENT MUTANTS OF CANDIDA-ALBICANS [J].
BULAWA, CE ;
MILLER, DW ;
HENRY, LK ;
BECKER, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10570-10574
[4]   Constitutive activation of the Saccharomyces cerevisiae mating response pathway by a MAP kinase kinase from Candida albicans [J].
Clark, KL ;
Feldmann, PJF ;
Dignard, D ;
Larocque, R ;
Brown, AJP ;
Lee, MG ;
Thomas, DY ;
Whiteway, M .
MOLECULAR AND GENERAL GENETICS, 1995, 249 (06) :609-621
[5]  
CSANK C, IN PRESS INFECT IMMU
[6]   Reduced virulence of Candida albicans MKC1 mutants: A role for mitogen-activated protein kinase in pathogenesis [J].
DiezOrejas, R ;
Molero, G ;
NavarroGarcia, F ;
Pla, J ;
Nombela, C ;
SanchezPerez, M .
INFECTION AND IMMUNITY, 1997, 65 (02) :833-837
[7]  
GHANNOUM MA, 1995, BAILLIERE CLIN INF D, V2, P1
[8]   ISOLATION OF THE CANDIDA-ALBICANS GENE FOR OROTIDINE-5'-PHOSPHATE DECARBOXYLASE BY COMPLEMENTATION OF S-CEREVISIAE URA3 AND ESCHERICHIA-COLI PYRF MUTATIONS [J].
GILLUM, AM ;
TSAY, EYH ;
KIRSCH, DR .
MOLECULAR & GENERAL GENETICS, 1984, 198 (01) :179-182
[9]   A MURINE MODEL FOR THE STUDY OF MYCOTIC MASTITIS [J].
GUHAD, FA ;
JENSEN, HE ;
AALBAEK, B ;
RYCROFT, A ;
HAU, J .
JOURNAL OF COMPARATIVE PATHOLOGY, 1995, 113 (04) :315-325
[10]   Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development [J].
Kohler, JR ;
Fink, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :13223-13228